Peer Review reports
From: Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
| Original Submission | ||
|---|---|---|
| 9 Jun 2022 | Submitted | Original manuscript |
| 1 Aug 2022 | Reviewed | Reviewer Report |
| 6 Aug 2022 | Reviewed | Reviewer Report |
| 9 Sep 2022 | Author responded | Author comments - Xingen Zhu |
| Resubmission - Version 2 | ||
| 9 Sep 2022 | Submitted | Manuscript version 2 |
| 24 Sep 2022 | Author responded | Author comments - Xingen Zhu |
| Resubmission - Version 3 | ||
| 24 Sep 2022 | Submitted | Manuscript version 3 |
| 2 Oct 2022 | Author responded | Author comments - Xingen Zhu |
| Resubmission - Version 4 | ||
| 2 Oct 2022 | Submitted | Manuscript version 4 |
| 13 Oct 2022 | Author responded | Author comments - Xingen Zhu |
| Resubmission - Version 5 | ||
| 13 Oct 2022 | Submitted | Manuscript version 5 |
| 7 Nov 2022 | Reviewed | Reviewer Report |
| 13 Nov 2022 | Reviewed | Reviewer Report |
| 23 Nov 2022 | Reviewed | Reviewer Report |
| 24 Nov 2022 | Reviewed | Reviewer Report |
| 1 Dec 2022 | Author responded | Author comments - Xingen Zhu |
| Resubmission - Version 6 | ||
| 1 Dec 2022 | Submitted | Manuscript version 6 |
| 17 Dec 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 26 Dec 2022 | Editorially accepted | |
| 9 Feb 2023 | Article published | 10.1186/s12885-022-10491-w |
You can find further information about peer review here.